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Human norovirus (HuNoV) is the leading cause of epidemic acute gastroenteritis worldwide. 
Type I interferons (IFN)-α/β are highly potent cytokines that are initially identified for their 
essential roles in antiviral defense. It was reported that HuNoV infection did not induce 
IFN-β expression but was controlled in the presence of IFN-β in human intestinal enteroids 
and a gnotobiotic pig model, suggesting that HuNoV has likely developed evasion 
countermeasures. In this study, we  found that a cDNA clone of GII.4 HuNoV, the 
predominantly circulating genotype worldwide, inhibits the production of IFN-β and 
identified the viral NTPase as a key component responsible for such inhibition. HuNoV 
NTPase not only inhibits the activity of IFN-β promoter but also the mRNA and protein 
production of IFN-β. Additional studies indicate that NTPase inhibits the phosphorylation 
and nuclear translocation of interferon-regulatory factor-3 (IRF-3), leading to the suppression 
of IFN-β promoter activation. Mechanistically, NTPase interacts with IkB kinase ε (IKKε), 
an important factor for IRF-3 phosphorylation, and such interaction blocks the association 
of IKKε with unanchored K48-linked polyubiquitin chains, resulting in the inhibition of IKKε 
phosphorylation. Further studies demonstrated that the 1-179 aa domain of NTPase 
which interacts with IKKε is critical for the suppression of IFN-β production. Our findings 
highlight the role of HuNoV NTPase in the inhibition of IFN-β production, providing insights 
into a novel mechanism underlying how HuNoV evades the host innate immunity.
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INTRODUCTION
Human norovirus (HuNoV) is a non-enveloped, single-stranded, positive-sense, RNA virus 
belonging to the caliciviridae family (Thorne and Goodfellow, 2014). The ~7.5  kb genome 
contains three open reading frames (ORFs) (Lambden et al., 1993). ORF1 encodes a nonstructural 
polyprotein that is cleaved by its own protease to generate at least six distinct proteins: p48, 
NTPase, p22, VPg, 3CLpro, and RdRP. ORF2 encodes the major capsid protein VP1, and 
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ORF3 encodes the minor capsid protein VP2, locating inside 
the viral capsid (Lu et al., 2015). The NTPase protein is cleaved 
by the viral protease at the 331-696 aa of the ORF1-encoded 
polyprotein, resulting in a mature protein with a length of 
366 aa and a molecular weight of 40 kDa (Belliot et al., 2003). 
NTPase plays a significant role in viral replication, such as 
(a) NTP-dependent helicase activity for unrolling of RNA 
helices, (b) NTP-independent chaperone activity for remodeling 
the RNA structure and thereby facilitating the annealing of 
the RNA chains, and (c) collaboration in RNA synthesis carried 
out by RdRP (Li et  al., 2018). Moreover, NTPase, VP1, RdRP, 
and p48 work coordinately in the HuNoV replication process. 
VPg plays a role in recruiting cellular translation initiation 
factors, while p48 and p22 have been reported to interfere 
with cell signaling pathways (Campillay-Veliz et  al., 2020). 
Norovirus has been subdivided into 10 different genogroups 
(GI-GX) (Chhabra et  al., 2019). Only GI, GII, and GIV infect 
human and cause acute gastroenteritis (Mulondo et  al., 2020). 
HuNoV is the leading cause of epidemic gastroenteritis worldwide 
(Bull et  al., 2010; Ahmed et  al., 2014; Brown et  al., 2017), 
resulting in high morbidity and mortality rates particularly 
in infants, young children, and the elderly (Campillay-Veliz 
et  al., 2020). Due to the lack of an efficient in vitro cell 
culture system and a suitable animal model, our current 
understanding of HuNoV infection and pathogenesis is 
largely limited.
Host innate immune responses induce the production of 
interferons (IFNs) and pro-inflammatory cytokines (Lee and 
Min, 2007; Newton and Dixit, 2012; Brubaker et  al., 2015). 
Type I IFN-α/β signaling promotes the production of interferon-
stimulated genes (ISGs) and confers fast antiviral protection 
(Haller et  al., 2006). It was reported that IFN-β was effective 
in suppressing HuNoV replication in HG23 cells harboring a 
self-replicating HuNoV subgenomic replicon (Chang et  al., 
2006a). In addition, HuNoV infection did not induce type 
I  IFN responses but was controlled in the presence of IFN-β 
in the gnotobiotic pig model and human intestinal enteroids 
(HIEs) (Souza et  al., 2007; Jung et  al., 2012; Lin et  al., 2019, 
2020; Hosmillo et  al., 2020). Furthermore, a GII.3 HuNoV 
cDNA clone, which efficiently generates double-stranded RNAs 
(Qu et  al., 2016), commonly as pathogen-associated molecular 
patterns recognized by cellular sensors (Said et  al., 2018), did 
not induce detectable type I IFN responses but rather inhibited 
IFN-β production (Qu et  al., 2016). All these together suggest 
that HuNoV has likely developed an unknown mechanism to 
counteract IFN-β production.
Interferon-regulatory factor-3 (IRF-3) signal pathway is known 
to play a critical role in innate immune responses for regulating 
IFN-β production (Sato et  al., 1998; Barnes et  al., 2002). The 
retinoic acid-inducible gene I (RIG-I) like receptor (RLR) family 
functions as major sensors of RNA viruses. Following viral 
infection, the helicase domain of RIG-I or melanoma 
differentiation-associated protein 5 (MDA5) of RLR family 
binds to dsRNA and the recruitment domain binds to 
mitochondrial antiviral signal protein, which is also known as 
IPS1 (Kell and Gale, 2015; Esser-Nobis et  al., 2020). IPS1 
activation enables IkB kinase ε (IKKε) and TANK-binding 
kinase 1 (TBK1) to phosphorylate and dimerize IRF-3 (Fitzgerald 
et  al., 2003; Fang et  al., 2017). IRF-3 translocates from the 
cytoplasm into the nucleus, resulting in transcription induction 
of the gene encoding IFN-β (Goubau et  al., 2013; Hartmann, 
2017). Several viral components from different viruses have 
been shown to inhibit IFN-β production via interfering with 
IRF-3 signal pathway (Fensterl et  al., 2005; Daffis et  al., 2007; 
Paulmann et  al., 2008). It is known that RNAs synthesized 
by transiently expressed HuNoV RdRP can stimulate RIG-I-
dependent reporter luciferase production via the IFN-β promoter 
(Subba-Reddy et al., 2011). However, it remains to be determined 
whether HuNoV modulates IFN-β production through RLR-IRF-3 
signal pathway.
In the current study, we  demonstrated that a GII.4 HuNoV 
cDNA clone inhibits IFN-β production and identified the viral 
NTPase as a key component responsible for such inhibition. 
We  further addressed how HuNoV NTPase inhibits IFN-β 
production and the key region of NTPase involved in the 
process. This study reveals a novel mechanism of HuNoV 
evading innate immunity, providing a basis for further 
understanding the complexity of HuNoV-host interactions.
MATERIALS AND METHODS
Cell Lines, Viruses, Plasmids, and Abs
Human epithelial cell line Caco-2, HEK 293T cell line, and 
HeLa cell line were maintained in DMEM (Life Technologies, 
11965), containing 100 U/ml penicillin, 100 U/ml streptomycin, 
and 10% FBS at 37°C in a 5% CO2 incubator. Sendai virus 
(SeV) was propagated in 12-d-old special pathogen-free 
embryonated eggs (Beijing Merial Vital Laboratory Animal 
Technology Corporation), and chicken red blood cells were 
used to measure the titer of SeV by hemagglutination assay 
(Killian, 2008). Eggs were incubated at 37°C for 12 d before 
inoculation with SeV. SeV was diluted to 100 hemagglutinating 
unit (HAU)/ml with FBS-free DMEM. Allantoic cavity of eggs 
was injected with 300  μl SeV diluent and incubated at 37°C 
for 72  h. The allantoic fluids were collected after eggs were 
kept in an incubator at 4°C overnight. Collected virus fluids 
were briefly centrifuged and stored at −80°C before being 
used for infection. For hemagglutination assay, equal volume 
of 1% (v/v) chicken RBCs was mixed with 2-fold serially diluted 
SeV before added to 96-well V-shaped bottom plates for 45 min 
at room temperature. The highest dilution of virus that formed 
diffuse lattice was defined as 1  HAU.
The plasmid pHuNoV containing full-length genome cDNA 
of GII.4 HuNoV was constructed using an established reverse 
Abbreviations: IFN, interferon; HuNoV, human norovirus; IKKε, IkB kinase ε; 
IRF-3, interferon-regulatory factor-3; HIEs, human intestinal enteroids; SeV, Sendai 
virus; Poly(I:C), polyinosinic-polycytidylic acid; siRNA, small interfering RNA; 
ISG, interferon-stimulated gene; RIG-I, retinoic acid-inducible gene I; MDA5, 
melanoma differentiation-associated protein 5; RLR, RIG-I-like receptor; ORF, 
open reading frame; MAVS, mitochondrial antiviral signal; TBK1, TANK-binding 
kinase 1; Ab, antibody; PCNA, proliferating cell nuclear antigen; TRIM6, tripartite 
motif-containing 6; HAU, hemagglutinating unit; Co-IP, coimmunoprecipitation; 
DLR, dual luciferase report; WB, Western blotting; IF, immunofluorescence.
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genetics system as described in the previous study (Katayama 
et  al., 2014). GII.4 HuNoV genes p48, NTPase, VPg, RdRP, 
NTPase, and its truncations with Flag or HA tag were cloned 
into the HindIII-BamHI sites of the pcDNA3.1(+) (Invitrogen), 
using NovoRec PCR one-step directional cloning kit 
(Novoprotein, NR001) according to the manufacturer’s 
instructions. P22 and 3CLpro genes of GII.4 HuNoV with a 
Flag tag were generated and inserted into the pcDNA3.1(+) 
vector by GenScript, respectively. The pcDNA3-IPS1-Flag 
expression plasmid, the IFN-β reporter plasmid p125-Luc, and 
the internal control plasmid phRL-TK were described previously 
(Cloutier and Flamand, 2010; Li et al., 2010). IRF-3/5D expression 
plasmid pIRES-hrGFP/IRF-3/5D-Flag (constitutively active 
mutant of IRF-3) was provided by Dr. Yi-Ling Lin (Graduate 
Institute of Life Sciences, National Defense Medical Center, 
Taipei, Taiwan) (Chang et  al., 2006b). The reporter plasmid 
PRD(III-I)4-Luc was provided by Dr. Stephan Ludwig (University 
of Muenster, Muenster, Germany) (Ehrhardt et  al., 2004). 
pEF-Flag-RIG-I-IN (a carboxy-terminally truncated, constitutively 
active RIG-I mutant) expression plasmid was provided by Dr. 
Takashi Fujita (Yoneyama et  al., 2004). Expression plasmids 
pcDNA3-TBK1-Flag and pcDNA3-IKKε-Flag were gifts from 
Dr. Katherine Fitzgerald (University of Massachusetts Medical 
School, Worcester, MA) (Fitzgerald et  al., 2003). All primers 
used are listed in Supplementary Table S1.
The antibody (Ab) against GII HuNoV capsid was purchased 
from Invitrogen (MA5-18241). Abs against IRF-3, p-IRF-3, 
IKKε, and p-IKKε were purchased from Cell Signaling 
Technology (4302S, 4947S, 2905S, and 8766S). A rabbit Ab 
against HA tag was purchased from Cell Signaling Technology 
(3724S), and another mouse Ab against HA tag was purchased 
from Santa Cruz Biotechnology (sc-7392). Ab against Flag tag 
was purchased from Sigma-Aldrich (F1804). Ab against β-actin 
was purchased from Santa Cruz Biotechnology (sc-81178). Ab 
against proliferating cell nuclear antigen (PCNA) was purchased 
from Proteintech (10205-2-AP). Alexa Fluor 488-labeled Goat 
Anti-Mouse IgG (H + L) (A0428) and Alexa Fluor 647-labeled 
Goat Anti-Rabbit IgG (H + L) (A0468) were from Beyotime. 
Polyinosinic-polycytidylic acid [Poly(I:C)] was purchased from 
InvivoGen (tlrl-picwlv).
Dual Luciferase Report Assay
HEK 293T cells preseeded in 48-well plates overnight were 
cotransfected with plasmid encoding NTPase, truncated NTPase, 
or empty vector together with IFN-β reporter plasmid p125-Luc 
and internal control plasmid phRL-TK. Transfections were 
performed using Lipofectamine 3,000 (Invitrogen, L3000015) 
according to the manufacturer’s instructions. At 24  h 
posttransfection, cells were stimulated with 100 HAU SeV 
or transfected with Poly(I:C) using Lipofectamine 2000 
(Invitrogen, 11668-027) according to the manufacturer’s 
instructions. The 16  h later, the lysates were harvested from 
cells and used to measure firefly and renilla luciferase activities 
with a Dual-Luciferase Reporter Assay System (Promega, 
E1980) according to the manufacturer’s instructions. For some 
experiments, NTPase expression plasmid or empty vector, 
reporter plasmid p125-Luc and phRL-TK, together with plasmid 
encoding IFN-β pathway inducer RIG-I-IN, IPS1, TBK1, IKKε, 
or IRF-3/5D was cotransfected into HEK 293T cells for 40  h. 
The enzymatic activities of firefly and renilla luciferase 
were measured.
Real-Time PCR
The NTPase expression plasmid or empty vector was transfected 
into HEK 293T cells preseeded in 6-well plates. At 24  h 
posttransfection, cells were stimulated with 100 HAU SeV or 
Poly(I:C) for 16  h. For some experiments, Caco-2 cells in 
6-well plates were transfected with NTPase expression plasmid 
or empty vector. At 24 h posttransfection, cells were stimulated 
with IFN-β or IFN-γ for 16  h. In some cases, Caco-2 cells 
in 6-well plates were transfected with pHuNoV or empty vector. 
At 24  h posttransfection, cells were stimulated with SeV or 
transfected with Poly(I:C) for 16 h. TRIzol (Invitrogen, 15596-026) 
was used to extract total RNA from cells according to the 
manufacturer’s instructions. The contamination of genomic 
DNA was eliminated with RNase-free DNase I  (Fermentas, 
EN0521). cDNA was synthesized by SMART MMLV Reverse 
Transcriptase (Takara, 639522) and used as the template for 
the amplification of IFN-β, ISGs, or internal GAPDH control. 
Real-time PCR was performed on an Bio-Rad CFX96 using 
the iTaq Universal SYBR Green Supermix (Bio-Rad, 1,725,124) 
according to the following conditions: 95°C for 30  s, followed 
by 40  cycles of 95°C for 5  s, and 60°C for 30  s. In some 
cases, Caco-2 cells in 6-well plates were transfected with 
pHuNoV. At the indicated time posttransfection, TRIzol 
(Invitrogen, 15596-026) was used to extract total RNA from 
cells according to the manufacturer’s instructions. Real-time 
PCR was performed on an Bio-Rad CFX96 using the HiScript 
® II One Step qRT-PCR SYBR Green Kit (Vazyme, Q221-01) 
according to the following conditions: 50°C for 3  min, 95°C 
for 30  s, followed by 40  cycles of 95°C for 10  s, and 60°C 
for 30  s. The expression difference was calculated on the basis 
of 2-ΔΔt values. The primer pairs used are listed in 
Supplementary Table S2.
ELISA for IFN-β
Plasmid expressing NTPase, truncated NTPase, or empty vector 
was transfected into HEK 293T cells preseeded in 6-well plates 
for 24  h followed by stimulation with 100 HAU SeV for 16  h. 
For some experiments, Caco-2 cells in 6-well plates were 
transfected with pHuNoV or empty vector. The 24  h 
posttransfection, cells were stimulated with SeV or transfected 
with Poly(I:C) for 16  h. Secreted IFN-β in supernatants was 
quantified by a human IFN-β ELISA kit (Pierce, 414101) 
according to the manufacturer’s instructions.
Western Blotting
Plasmid expressing NTPase, truncated NTPase, or empty vector 
was transfected into HEK 293T cells preseeded in 6-well plates 
for 24  h followed by stimulation with 100 HAU SeV for 16  h. 
Total proteins were released using the Cell Lysis Buffer (Thermo 
Fisher, 87788). Cytoplasmic and nuclear proteins were isolated 
using the Nucleus and Cytoplasm Protein Extraction Kit 
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(Beyotime, P0027). For some experiments, Caco-2 cells in 
6-well plates were transfected with pHuNoV or empty vector 
for 24  h. Cell extracts were subjected to 10% SDS-PAGE and 
transferred to polyvinylidene difluoride membranes (Millipore, 
0.45  mm). The membrane was incubated with 5% nonfat milk 
in TBS-Tween [200  mm NaCl, 0.1% (v/v) Tween 20, 50  mm 
Tris-HCl (pH 7.5)] for 2 h and then incubated with appropriate 
primary Abs at room temperature for 2  h. The membrane 
was washed three times with TBS-Tween followed by incubation 
with HRP-conjugated goat anti-mouse IgG (Beyotime, A0216) 
or HRP-conjugated goat anti-rabbit IgG (Beyotime, A0208) at 
room temperature for 1  h. Following the addition of 
chemiluminescent substrates (Beyotime, P0018), protein bands 
were visualized under a FluorChem HD2 Imaging System (α 
Innotech). For some experiments, blot intensity was quantified 
using the software Image Lab.
Immunofluorescence Assay
HeLa cells preseeded in 6-well plates were transfected with 
plasmid expressing NTPase, truncated NTPase, or empty vector. 
24  h later, cells were stimulated with 100 HAU SeV for 16  h. 
After fixation with 4% paraformaldehyde, cells were permeabilized 
with 0.2% Triton X-100. Cell were washed three times with 
PBS and blocked with PBS containing 3% BSA at 4°C overnight. 
Subsequently, cells were incubated with rabbit anti-human IRF-3 
Ab (Cell Signaling Technology, 4302S) and mouse anti-HA 
polyclonal Ab (Santa Cruz Biotechnology, sc-7392) at a dilution 
of 1:100 at 37°C for 1  h. After three washes with PBS, cells 
were then incubated with Alexa Fluor 488-labeled Goat Anti-
Mouse IgG (H + L) (Beyotime, A0428) and Alexa Fluor 
647-labeled Goat Anti-Rabbit IgG (H + L) (Beyotime, A0468) 
at a dilution of 1:100 each for 1  h at 37°C. Thereafter, cells 
were washed three times with PBS and incubated with DAPI 
(Beyotime, C1005) for 5  min at room temperature. After three 
washes with PBS, cells were observed under a fluorescence 
microscope (Nikon, N-STORM).
RNA Interference
The sequence of small interfering RNA (siRNA) for HuNoV 
NTPase (5'-CCACTTTAAGAGCTTGTAA-3'), siRNA for 
tripartite motif-containing 6 (TRIM6) 
(5'-GCTGCTTCAAGTCCTTGGCTCTGAT-3'), and a siRNA 
for scrambled negative control sequence were synthesized by 
the RiboBio. Caco-2 cells were transfected with siRNA for 
HuNoV NTPase or control siRNA using the riboFECT CP 
Transfection Kit (RiboBio, C10511-1) according to the 
manufacturer’s instructions. 24  h posttransfection, cells were 
transfected with pHuNoV or empty vector for another 24  h. 
Supernatants were quantified by a human IFN-β ELISA kit 
(Pierce, 414101) according to the manufacturer’s instructions. 
TRIzol (Invitrogen, 15596-026) was used to extract total RNA 
from cells according to the manufacturer’s instructions. cDNA 
was synthesized by the SMART MMLV Reverse Transcriptase 
(Takara, 639522) and used to perform real-time PCR. For 
some experiments, siRNA for HuNoV NTPase or control siRNA 
was transfected into Caco-2 cells. At 24  h posttransfection, 
cells were transfected with NTPase-Flag expression plasmid or 
empty vector for another 24  h. Total protein was isolated. The 
NTPase expression was confirmed by Western blotting (WB) 
using anti-Flag Ab. For some experiments, TRIM6-specific 
siRNA or control siRNA was transfected into HEK 293T cells. 
At 24 h posttransfection, cells were cotransfected with NTPase-HA 
expression plasmid or empty vector, reporter plasmid p125-Luc 
and phRL-TK, together with plasmid encoding IFN-β inducer 
RIG-I-IN-Flag for another 24  h. The enzymatic activities of 
firefly and renilla luciferase were measured. Total protein was 
isolated and the expression of TRIM6, RIG-I-IN-Flag, and 
NTPase-HA was analyzed by WB using anti-TRIM6 Ab, anti-
Flag Ab, and anti-HA Ab, respectively.
Coimmunoprecipitation Assay
NTPase-HA or truncated NTPase-HA expression plasmid 
together with IKKε-Flag expression plasmid or empty vector 
was cotransfected into HEK 293T cells preseeded in 6-well 
plates. For some experiments, IKKε-Flag expression plasmid 
together with plasmid expressing NTPase-HA, truncated 
NTPase-HA, or empty vector was cotransfected into HEK 293T 
cells preseeded in 6-well plates. 24 h later, cells were stimulated 
with or without 100 HAU SeV for 16  h. Lysis buffer [150  mm 
NaCl, 1% NP40, 50  mm Tris (pH 8.0)] containing protease 
inhibitor mixture (Roche, 11,697,498,001) was used to lysis 
cells on ice for 10  min. To eliminate the nonspecific binding 
of other proteins, Dynabeads protein G (Invitrogen, 10003D) 
was used to pretreat the samples for 2  h at room temperature. 
5  μg mouse anti-Flag Ab, 5  μg rabbit anti-HA Ab, or control 
IgG together with fresh Dynabeads protein G were added to 
the pretreated samples followed by a rotary incubator at 4°C 
overnight. After three washes with PBST, the target Ags were 
subjected to WB analysis after elution by boiling.
Statistical Analysis
Data analyses were performed with the GraphPad Prism 7 
software (GraphPad). Comparison between two groups was 
analyzed by two-tailed unpaired student t-test. A value of 
p  <  0.05 was considered statistically significant.
RESULTS
The cDNA Clone of HuNoV Inhibits IFN-β 
Production
Due to the lack of an efficient cell culture system in vitro and 
a suitable animal model, the understanding of HuNoV infection 
and host immune responses to the virus is largely limited. 
Recently, a GII.3 HuNoV clone constructed using a reverse 
genetics system has been shown to inhibit IFN-β production 
in 293FT cells (Qu et  al., 2016), highlighting the potential of 
such system in HuNoV research. Given that the GII.4 genotype 
is the most prevalent HuNoV in the world and that GII.3 
and GII.4 HuNoV may exhibit strain-specific sensitivity to host 
IFN pathways (Lin et al., 2020), we employed a plasmid pHuNoV 
containing full-length genome cDNA of GII.4 HuNoV constructed 
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using our established reverse genetics system to address its 
impact on IFN-β production. The structural proteins of HuNoV 
can be  detected in cells transfected with HuNoV cDNA clone 
in Caco-2 cells (Oliveira et  al., 2018). We  first confirmed the 
expression of HuNoV NTPase RNA and VP1 protein in the 
cells transfected with GII.4 HuNoV cDNA clone (Figures 1A,B). 
Caco-2 cells were transfected with pHuNoV or empty vector 
for 24  and then stimulated with or without SeV for 16  h. 
Real-time PCR and ELISA were performed to analyze mRNA 
and protein production of IFN-β, respectively. As shown in 
Figures 1C,D, the cDNA clone of HuNoV significantly inhibited 
the mRNA and protein expression of IFN-β induced by SeV. 
In addition to SeV stimulation, we also conducted experiments 
under the condition of IFN-β expression induced by Poly(I:C). 
As shown in Figures 1E,F, the cDNA clone of HuNoV inhibited 
the mRNA and protein expression of IFN-β induced by Poly(I:C). 




FIGURE 1 | A cDNA clone of human norovirus (HuNoV) inhibits the production of interferons (IFN-β) induced by Sendai virus (SeV) and polyinosinic-polycytidylic 
acid [Poly(I:C)]. (A) Identification of HuNoV RNA expression in cells transfected with a HuNoV cDNA clone. 3 μg pHuNoV was transfected into Caco-2 cells 
preseeded in 6-well plates. At the indicated time posttransfection, total RNA was extracted from transfected cells to measure NTPase RNA by real-time PCR. 
(B) Identification of HuNoV protein expression in cells transfected with a HuNoV cDNA clone. 3 μg pHuNoV or empty vector was transfected into Caco-2 cells 
preseeded in 6-well plates for 24 h. Total proteins were isolated. HuNoV VP1 was detected using an anti-HuNoV VP1 Ab, with β-actin being used as a loading 
control. (C,D) A cDNA clone of HuNoV inhibits the production of IFN-β induced by SeV. 3 μg pHuNoV or empty vector was transfected into Caco-2 cells preseeded 
in 6-well plates. At 24 h posttransfection, cells were stimulated with or without SeV for 16 h. Total RNA was extracted from transfected cells to measure IFN-β 
mRNA by real-time PCR (C), while IFN-β released in supernatants was determined by ELISA (D). (E,F) A cDNA clone of HuNoV inhibits the production of IFN-β 
induced by Poly(I:C). Caco-2 cells in 6-well plates were transfected with 3 μg pHuNoV or empty vector. 24 h later, cells were transfected with or without 0.5 μg/ml 
Poly(I:C) for 16 h. Total RNA was extracted from transfected cells to measure IFN-β mRNA by real-time PCR (E), while IFN-β released in supernatants was 
determined by ELISA (F). One representative experiment out of three is shown for WB. For graphs, data shown are mean ± SD of three independent experiments, 
with each condition performed in triplicate. ***p < 0.001; **p < 0.01.
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HuNoV NTPase Inhibits IFN-β Production
Subsequently, experiments were conducted to address the potential 
role of HuNoV proteins in inhibiting IFN-β induction. Reporter 
plasmid p125-luc and phRL-TK together with HuNoV gene 
(p48, NTPase, p22, VPg, 3CLpro, RdRP, VP1, or VP2) expression 
plasmid or empty vector were cotransfected into HEK 293T 
cells. At 24  h posttransfection, cells were stimulated with or 
without SeV for 16 h. Reporter activities were determined with 
dual luciferase report (DLR) assay. As shown in Figure  2A; 
Supplementary Figure S1, HuNoV NTPase and p22, but not 
p48, VPg, 3CLpro, RdRP, VP1, or VP2, significantly inhibited 
the activation of IFN-β promoter. Given that the inhibitory 
effect of NTPase on the IFN-β promoter activity appeared to 
be  stronger than that of p22, we  subsequently focused on 
understanding the mechanism as to how HuNoV NTPase inhibits 
IFN-β production. To further confirm the effect of NTPase 
on the activation of IFN-β promoter, HEK 293T cells were 
cotransfected with reporter plasmid p125-luc and phRL-TK 
together with various amounts of NTPase expression plasmid 
for 24  h followed by stimulation with or without SeV for 
16  h. As shown in Figure  2B, HuNoV NTPase suppressed the 
activation of IFN-β promoter in a dose-dependent manner. To 
confirm the results generated from DLR assay, IFN-β production 
at the mRNA and protein levels was also analyzed by real-time 
PCR and ELISA, respectively. As shown in Figure  2C, HuNoV 
NTPase inhibited the mRNA and protein expression of IFN-β 
induced by SeV in a dose-dependent manner. In addition to 
SeV stimulation, we conducted experiments under the condition 
of IFN-β expression induced by Poly(I:C). p125-Luc and phRL-TK 
together with plasmid expressing NTPase or empty vector were 
cotransfected into HEK 293T cells. At 24  h posttransfection, 
cells were subsequently transfected with or without Poly(I:C) 
for 16  h to induce IFN-β expression. As shown in Figure  2D, 
the activation of IFN-β promoter induced by Poly(I:C) was 
inhibited by HuNoV NTPase. We  further assessed IFN-β 
production induced by Poly(I:C) at mRNA level. HuNoV NTPase 
significantly inhibited the mRNA expression of IFN-β induced 
by Poly(I:C) (Figure  2E). Moreover, the HuNoV cDNA clone 
with NTPase knockdown increased the expression of IFN-β 
and ISGs (Supplementary Figure S2). These findings together 
demonstrate that HuNoV NTPase suppresses IFN-β production.
HuNoV NTPase Suppresses IRF-3 
Phosphorylation and Nuclear 
Translocation
Having identified HuNoV NTPase as an important viral protein 
responsible for IFN-β inhibition, we next assessed the potential 
signal pathway involved in NTPase-mediated inhibition of 
IFN-β production. IRF-3 signal pathway is known to have a 
critical role in viral and bacterial innate immune responses 
by regulating the production of IFN-β (Sato et al., 1998; Barnes 
et  al., 2002). Several viral components from different viruses 
have been shown to inhibit IFN-β production via interfering 
with IRF-3 signal pathway (Fensterl et  al., 2005; Daffis et  al., 
2007; Paulmann et  al., 2008). We  therefore determined the 
effects of NTPase on IRF-3 signal pathway. PRD(III-I)4-Luc 
containing four repeats of the IRF-3 responsive domain of 
IFN-β promoter and phRL-TK together with NTPase-expressing 
plasmid or empty vector was cotransfected into HEK 293T 
cells for 24  h. Cells were subsequently stimulated with or 
without SeV for 16  h followed by DLR assay. The activation 
of IRF-3 responsive promoter was induced by SeV in cells 
transfected with the empty vector, while the activation was 
blocked by NTPase in a dose-dependent manner (Figure  3A). 
It is likely that IFN-β production was inhibited by NTPase 
through IRF-3 dependent signal pathway. Upon activation, 
IRF-3 phosphorylates and translocates from the cytoplasm to 
the nucleus, resulting in transcription induction of the gene 
encoding IFN-β (Goubau et  al., 2013; Hartmann, 2017). 
We further verified the effect of NTPase on the phosphorylation 
and translocation of IRF-3. To analyze IRF-3 phosphorylation, 
cells transfected with plasmid expressing NTPase or empty 
vector were stimulated with SeV to activate IRF-3 signal 
pathway. As shown in Figure 3B, the phosphorylation of IRF-3 
induced by SeV was inhibited by NTPase. Nuclear translocation 
of IRF-3 was analyzed in cells transfected with plasmid expressing 
NTPase or empty vector and stimulated with SeV to induce 
IRF-3 translocation from the cytoplasm to the nucleus. 
Cytoplasmic and nuclear proteins were subsequently isolated 
from HEK 293T cells followed by WB to determine the 
distribution of IRF-3. As shown in Figures 3C,D, IRF-3 nuclear 
translocation significantly decreased in cells transfected with 
NTPase expression plasmid. To further confirm the results, 
HeLa cells were transfected with NTPase expression plasmid 
or empty vector. At 24 h posttransfection, cells were stimulated 
with or without SeV for 16  h and examined by indirect 
immunofluorescence (IF). As shown in Figure  3E, after 
stimulation with SeV, IRF-3  in cells transfected with empty 
vector mostly located in the nucleus, whereas IRF-3 nuclear 
localization significantly decreased in cells transfected with 
NTPase expression plasmid. These data collectively indicate 
that HuNoV NTPase inhibits the activation of IRF-3.
HuNoV NTPase Interrupts IFN-β 
Production at the Stage of TBK1/IKKε 
Kinases in IRF-3 Signal Pathway
It is known that HuNoV replication efficiently generates double-
stranded RNA (Qu et  al., 2016). RIG-I can bind to dsRNA 
and signal cascade through the adaptor IPS1  in response to 
foreign RNA (Esser-Nobis et al., 2020; Schweinoch et al., 2020). 
Two protein kinase complex, TBK1/IKKε is engaged to initiate 
RIG-I signal, leading to the phosphorylation and further 
activation of IRF-3 (Fitzgerald et  al., 2003; Fang et  al., 2017). 
To identify the potential mechanism by which NTPase inhibits 
IFN-β production, HEK 293T cells were cotransfected with 
p125-Luc, phRL-TK, NTPase expression plasmid, or empty 
vector, together with plasmid expressing RIG-I-IN, IPS1, TBK1, 
IKKε, or IRF-3/5D, which are inducers of IFN-β in the IRF-3 
signal pathway. As shown in Figures  4A-E, overexpression of 
RIG-I-IN (Figure  4A), IPS1 (Figure  4B), TBK1 (Figure  4C), 
IKKε (Figure  4D), or IRF-3/5D (Figure  4E) directly induced 
the activation of IFN-β promoter, which is consistent with a 
previous study (Jaworska et al., 2007). As shown in Figures 4A-E, 
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FIGURE 2 | HuNoV NTPase inhibits IFN-β production induced by SeV and Poly(I:C) in a dose-dependent manner. (A) Identification of HuNoV proteins that inhibit 
IFN-β expression. 200 ng plasmid expressing Flag-tagged p48, NTPase, VPg, RdRP, VP1, VP2, or empty vector together with 100 ng p125-Luc and 20 ng phRL-TK 
was cotransfected into HEK 293T cells preseeded in 48-well plates for 24 h. Cells were stimulated with or without SeV for 16 h. Reporter activities were determined 
with dual luciferase report (DLR) assay. The expression of HuNoV proteins was analyzed by WB using an anti-Flag Ab. An asterisk indicates HuNoV protein. 
(B) HuNoV NTPase inhibits SeV-induced activation of IFN-β promoter. Various amounts of Flag-tagged NTPase expression plasmid or empty vector together with 
100 ng p125-Luc and 20 ng phRL-TK were cotransfected into HEK 293T cells preseeded in 48-well plates for 24 h. Cells were stimulated with or without SeV for 
16 h. Reporter activities were determined with DLR assay. (C) HuNoV NTPase inhibits the SeV-induced production of IFN-β. HEK 293T cells in 6-well plates were 
(Continued)
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FIGURE 2 | transfected with various amounts of plasmid expressing NTPase or empty vector for 24 h followed by stimulation with or without SeV for 16 h. Total 
RNA was extracted from transfected cells to measure IFN-β mRNA by real-time PCR, while IFN-β released in supernatants was determined by ELISA. (D) HuNoV 
NTPase inhibits Poly(I:C)-induced activation of IFN-β promoter. HEK 293T cells in 48-well plates were cotransfected with various amounts of Flag-tagged NTPase 
expression plasmid or empty vector together with 100 ng p125-Luc and 20 ng phRL-TK. At 24 h posttransfection, cells were transfected with or without 0.5 μg/ml 
Poly(I:C) for 16 h. Reporter activities were determined with DLR assay. (E) HuNoV NTPase inhibits the Poly(I:C)-induced production of IFN-β mRNA. HEK 293T cells 
in 6-well plates were transfected with various amounts of plasmid expressing NTPase or empty vector for 24 h followed by transfection with or without 0.5 μg/ml 
Poly(I:C) for 16 h. Total RNA was extracted from transfected cells to measure IFN-β mRNA by real-time PCR. The expression of HuNoV NTPase protein was detected 
using an anti-Flag Ab or anti-HA Ab, with β-actin being used as a loading control. One representative experiment out of three is shown for WB. For graphs, data 





FIGURE 3 | HuNoV NTPase suppresses IRF-3 phosphorylation and translocation. (A) HuNoV NTPase inhibits the activation of IRF-3-responsive IFN-β promoter. 
Various amounts of NTPase-Flag expression plasmid or empty vector together with 100 ng PRD(III-I)4-Luc and 20 ng phRL-TK were cotransfected into HEK 293T 
(Continued)
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NTPase suppressed the activation of IFN-β promoter induced 
by RIG-I-IN, IPS1, TBK1, and IKKε in a dose-dependent 
manner, but had no effect on the activation of IFN-β promoter 
induced by IRF-3. These results indicate that NTPase inhibits 
the production of IFN-β at the stage of TBK1/IKKε kinases 
in IRF-3 signal pathway.
FIGURE 3 | cells preseeded in 48-well plates for 24 h. Cells were stimulated with or without SeV for 16 h. Reporter activities were determined with DLR assay. 
(B) HuNoV NTPase inhibits the phosphorylation of IRF-3. HEK 293T cells in 6-well plates were transfected with 3 μg plasmid expressing NTPase or empty vector for 
24 h followed by stimulation with or without SeV for 16 h. Total protein was isolated. WB was performed to examine IRF-3 and p-IRF-3 using corresponding Abs. 
The expression of NTPase was monitored using the anti-Flag Ab. (C) HuNoV NTPase inhibits IRF-3 nuclear translocation. 3 μg NTPase expression plasmid or empty 
vector was transfected into HEK 293T cells preseeded in 6-well plates. 24 h later, cells were stimulated with or without SeV for 16 h. Cytoplasmic and nuclear 
proteins were isolated. IRF-3 levels were measured with anti-IRF-3 Ab. β-actin and PCNA were used as loading controls for cytoplasmic and nuclear proteins, 
respectively. (D) Blot intensity for nuclear IRF-3 was quantified using Image Lab with statistical significance being analyzed from three independent experiments. 
(E) The effect of NTPase on IRF-3 nuclear translocation was determined by indirect IF. HeLa cells in 35-mm dishes were transfected with 3 μg HA-tagged NTPase 
expression plasmid or empty vector for 24 h and then stimulated with or without SeV for 16 h. Cells were incubated with mouse anti-HA Ab and rabbit anti-IRF-3 
pAb, followed by Alexa Fluor 488-labeled Goat Anti-Mouse IgG (H + L) (green) and Alexa Fluor 647-labeled Goat Anti-Rabbit IgG (H + L) (red) as the secondary Abs. 
Cell nuclei (blue) were stained with DAPI. The images were acquired by fluorescence microscopy using a 60 × objective. One representative experiment out of three 
is shown. One representative experiment out of three is shown for WB. CE, cytoplasmic protein extract; NE, nuclear protein extract. For graphs, data shown are 




FIGURE 4 | HuNoV NTPase blocks IRF-3 signaling at the stage of tANK-binding kinase 1 (TBK1)/IKKε kinase. (A-E) Various amounts of HA-tagged NTPase 
expression plasmid or empty vector together with 100 ng p125-Luc and 20 ng phRL-TK, together with 20 ng retinoic acid-inducible gene (RIG)-I-IN (A), IPS1 (B), 
TBK1 (C), IKKε (D), or IRF-3/5D (E) expression plasmid were cotransfected into HEK 293T cells preseeded in 48-well plates for 40 h. Cells were harvested and 
luciferase activities were measured with DLR assay. Protein expression was monitored by WB using anti-HA or anti-Flag Ab. β-actin was used as a loading control. 
One representative experiment out of three is shown for WB. For graphs, data shown are mean ± SD of three independent experiments, with each condition 
performed in triplicate. ***p < 0.001; **p < 0.01; and ns, not significant.
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HuNoV NTPase Inhibits IKKε 
Phosphorylation via a Physical Interaction
IKKε and TBK1 are essential components of IRF-3 activation 
(Fitzgerald et al., 2003; tenOever et al., 2004; Fang et al., 2017). 
We  hypothesized that NTPase may interfere with the function 
of TBK1 or IKKε via the interaction. To test this hypothesis, 
coimmunoprecipitation (Co-IP) was performed to determine 
the interaction between NTPase and TBK1 or IKKε. HEK 
293T cells were cotransfected with plasmid expressing IKKε-
Flag together with NTPase-HA expression plasmid or empty 
vector for 40  h. Precleared cell lysates from the transfected 
cells were incubated with the HA Ab against NTPase-HA. The 
precipitates were analyzed by WB using anti-Flag Ab against 
Flag-tagged IKKε. As shown in Figure  5A, the anti-HA Ab 
was able to specifically precipitate the immune complex that 
contained NTPase-HA and IKKε-Flag. To further confirm the 
physical association of NTPase with IKKε, plasmid expressing 
NTPase-HA together with IKKε-Flag expression plasmid or 
empty vector was cotransfected into HEK 293T cells for 40  h. 
Precleared cell lysates from the transfected cells were incubated 
with anti-Flag Ab against IKKε-Flag. The precipitates were 
analyzed by WB using anti-HA Ab against HA-tagged NTPase. 
As shown in Figure 5B, the anti-Flag Ab was able to specifically 
precipitate the immune complex that contained IKKε-Flag and 
NTPase-HA. The Co-IP results indicated that NTPase interacted 
with IKKε, but had no interaction with TBK1 (data not shown). 
We  then asked whether NTPase affects the activation and 
function of IKKε. Phosphorylation of IKKε was analyzed in 
cells transfected with plasmid expressing NTPase or empty 
vector and stimulated with SeV to activate IRF-3 signal pathway. 
As expected, after the stimulation with SeV, IKKε phosphorylation 
was induced in cells transfected with empty vector but 
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FIGURE 5 | HuNoV NTPase interacts with IKKε and inhibits its phosphorylation. (A,B) HuNoV NTPase interacts with IKKε. (A) HEK 293T cells in 6-well plates were 
cotransfected with 1.5 μg plasmid expressing Flag-tagged IKKε together with 1.5 μg HA-tagged NTPase expression plasmid or empty vector for 40 h. Cells were lysed and 
subjected to coimmunoprecipitation (Co-IP) using rabbit anti-HA Ab. (B) HEK 293T cells in 6-well plates were cotransfected with 1.5 μg HA-tagged NTPase expression 
plasmid together with 1.5 μg plasmid expressing Flag-tagged IKKε or empty vector for 40 h. A mouse anti-Flag Ab was used for Co-IP of cell lysates with normal IgG being 
used as a negative control. IP products and 5% input samples were examined by WB using anti-HA and anti-Flag Abs. (C) HuNoV NTPase inhibits the phosphorylation of 
IKKε. HEK 293T cells in 6-well plates were transfected with 3 μg plasmid expressing NTPase or empty vector for 24 h and then stimulated with or without SeV for 16 h. 
Total protein was isolated. WB was performed to examine IKKε and p-IKKε using corresponding Abs. The expression of NTPase was monitored using anti-Flag Ab. 
(D) Blot intensity for p-IKKε was quantified using Image Lab with statistical significance being analyzed from three independent experiments. One representative experiment 
out of three is shown for WB. For graphs, data shown are mean ± SD of three independent experiments, with each condition performed in triplicate. *p < 0.05.
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significantly decreased in cells transfected with NTPase expression 
plasmid (Figures 5C,D). These results indicate that the interaction 
of NTPase with IKKε likely results in the inhibition of 
IKKε phosphorylation.
The 1-179 aa Domain of NTPase Is 
Important in Inhibiting IFN-β Production
Mitochondrion functions as a signaling platform for RLRs 
(Cloonan and Choi, 2013; Banoth and Cassel, 2018). Two 
mitochondrion targeting domains were identified in the 
C-terminal region (96-366 aa) of GII.4-NTPase (Yen et  al., 
2018). It is tempting to know whether NTPase-mediated 
inhibition of IFN-β production is related to its mitochondrial 
location. To map the functional region of NTPase involved 
in the inhibition of IFN-β production, we  constructed five 
truncation mutants including NTPase (1-95 aa), NTPase (1-179 
aa), NTPase (1-217 aa), NTPase (96-366 aa), and NTPase 
(180-366 aa) according to its subcellular localization and 
interaction domain (Yen et  al., 2018). Plasmid expressing 
NTPase, truncated NTPase, or empty vector together with 
p125-luc and phRL-TK was cotransfected into HEK 293T 
cells. At 24  h posttransfection, cells were stimulated with or 
without SeV for 16  h. Reporter activities were determined 
with DLR assay. As seen in Figure  6A, the mutants with N 
terminal region deletion [NTPase (96-366 aa) and NTPase 
(180-366 aa)] barely suppressed the activation of IFN-β 
promoter induced by SeV, whereas the mutants with C terminal 
region deletion [NTPase (1-179 aa) and NTPase (1-217 aa)] 
significantly inhibited the activation of IFN-β promoter. 
We  further confirm our findings generated from DLR assay 
at protein level. NTPase or its truncated mutant expression 
plasmid, or empty vector was transfected into HEK 293T 
cells. At 24  h posttransfection, cells were stimulated with or 
without SeV for 16 h. The IFN-β in supernatants was measured 
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FIGURE 6 | The 1-179 aa domain of NTPase is important in inhibiting IFN-β production. (A) The 1-179 aa and 1-217 aa domains of NTPase significantly inhibit the 
activation of IFN-β promoter. 200 ng NTPase, truncated NTPase expression plasmid, or empty vector together with 100 ng p125-Luc and 20 ng phRL-TK was 
cotransfected into HEK 293T cells preseeded in 48-well plates for 24 h followed by stimulation with or without SeV for 16 h. Reporter activities were determined with 
DLR assay. (B) The 1-179 aa and 1-217 aa domains of NTPase inhibit the production of IFN-β. 3 μg NTPase, truncated NTPase expression plasmid, or empty 
vector was transfected into HEK 293T cells preseeded in 6-well plates. At 24 h posttransfection, cells were stimulated with or without SeV for 16 h. The protein level 
of IFN-β in supernatants was measured by ELISA. (C) The expression of NTPase and truncated NTPase is determined by anti-HA Ab. One representative 
experiment out of three is shown for WB. For graphs, data shown are mean ± SD of three independent experiments, with each condition performed in triplicate. 
***p < 0.001; ns, not significant.
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by ELISA. In agreement with the results generated from DLR 
assay, NTPase (1-179 aa) and NTPase (1-217 aa) but not 
NTPase (1-95 aa), NTPase (96-366 aa), or NTPase (180-366 
aa) inhibited IFN-β production at protein level (Figure  6B). 
The expression of NTPase and truncated NTPase was confirmed 
as shown in Figure  6C. Taken together, these results indicate 
that the 1-179 aa domain of HuNoV NTPase is important 
in inhibiting IFN-β production.
The 1-179 aa Domain of NTPase Inhibits 
the Production of IFN-β in the Same 
Manner as Full-Length NTPase
Because NTPase inhibits IFN-β production by inhibiting IRF-3 
activation via targeting IKKε, the 1-179 aa domain of NTPase 
likely interferes with IFN-β production in the same manner 
as full-length NTPase. Subsequent experiments were conducted 
to address the mechanism of NTPase (1-179 aa) suppressing 
IFN-β production. We  firstly analyzed the phosphorylation of 
IKKε and IRF-3  in cells transfected with NTPase or truncated 
NTPase expression plasmid or empty vector followed by 
stimulation with SeV to activate IRF-3 signal pathway. As shown 
in Figure  7A, NTPase and NTPase (1-179 aa) but not NTPase 
(180-366 aa) inhibited the phosphorylation levels of IKKε and 
IRF-3 induced by SeV. Of interest, the truncation mutant NTPase 
(1-179 aa) appeared to inhibit IKKε phosphorylation in a 
stronger manner than did the full-length NTPase. HEK 293T 
cells transfected with plasmid expressing NTPase, truncated 
NTPase, or empty vector for 24  h were stimulated with SeV 
for 16  h to induce IRF-3 translocation from the cytoplasm to 
the nucleus. Cytoplasmic and nuclear proteins were subsequently 
isolated from HEK 293T cells, followed by WB to determine 
the distribution of IRF-3. NTPase and NTPase (1-179 aa) but 
not NTPase (180-366 aa) significantly inhibited IRF-3 nuclear 
translocation. Moreover, the truncation mutant NTPase (1-179 
aa) appeared to inhibit the nuclear translocation of IRF-3 more 
robustly than did the full-length NTPase (Figure 7B). To further 
confirm the results, HeLa cells were transfected with NTPase 
expression plasmid, truncated NTPase expression plasmid, or 
empty vector for 24  h followed by stimulation with or without 
SeV for 16  h. Cells were examined by indirect IF. As shown 
in Figure  7C, under SeV stimulation, in comparison with cells 
transfected with empty vector, nuclear IRF-3 decreased in cells 
transfected with NTPase or NTPase (1-179 aa) expression 
plasmid but not those with NTPase (180-366 aa) expression 
plasmid. Plasmid expressing NTPase-HA or truncated 
NTPase-HA together with IKKε-Flag expression plasmid or 
empty vector was cotransfected into HEK 293T cells for 40  h. 
Precleared cell lysates from the transfected cells were incubated 
with anti-Flag Ab against IKKε-Flag, and the precipitates were 
analyzed by WB using anti-HA Ab against HA-tagged NTPase. 
As shown in Figure 7D, the anti-Flag Ab was able to specifically 
precipitate the immune complex that contained IKKε, NTPase, 
and NTPase (1-179 aa), but not NTPase (180-366 aa). These 
results together suggest that the 1-179 aa domain inhibits IFN-β 
production in the same manner as the full-length NTPase and 
that the mutant NTPase (1-179 aa) inhibits IRF-3 nuclear 
translocation and IKKε phosphorylation more robustly than 
does the full-length NTPase.
HuNoV NTPase and 1-179 aa Domain 
Block the Association of IKKε With 
Unanchored K48-Linked Polyubiquitin 
Chains
Ubiquitination of IKKε is involved in the control of its kinase 
activation and is required for inducing IRF-3 phosphorylation 
and nuclear localization to activate IFN-β promoter (Ikeda et al., 
2007). Unanchored K48-linked polyubiquitin chains interact with 
IKKε and promote its oligomerization and autophosphorylation, 
leading to the activation of IKKε (Rajsbaum et al., 2014b; Bharaj 
et al., 2016). Subsequent experiments were conducted to examine 
whether NTPase suppresses the interaction of IKKε with 
K48-linked polyubiquitin chains. Plasmid expressing NTPase-HA 
or truncated NTPase-HA together with IKKε-Flag expression 
plasmid or empty vector was cotransfected into HEK 293T cells 
for 40  h. Precleared cell lysates from the transfected cells were 
incubated with anti-Flag Ab against IKKε-Flag. The precipitates 
were analyzed by WB using anti-K48-linked polyubiquitin. As 
shown in Figures 8A,B, the anti-Flag Ab against IKKε-Flag was 
able to specifically precipitate the immune complex that contained 
IKKε and K48-linked unanchored polyubiquitin chains, but 
K48-linked unanchored polyubiquitin chains of the precipitation 
significantly decreased in NTPase- or its truncation 1-179 
aa-transfected cells. TRIM6, a member of the TRIM E3-ubiquitin 
ligase family, associates with IKKε and catalyzes the synthesis 
of unanchored K48-linked polyubiquitin chains (Rajsbaum et al., 
2014b; Bharaj et al., 2016). We performed additional experiments 
to confirm whether NTPase blocks the association of IKKε with 
TRIM6. As shown in Figures  8C,D, the anti-Flag Ab against 
IKKε-Flag was able to specifically precipitate the immune complex 
that contained IKKε and TRIM6, and the precipitated TRIM6 
decreased in NTPase- or its truncation 1-179 aa- but not 180-366 
aa-transfected cells. To test whether K48-linked polyubiquitin 
chains synthesized by TRIM6 have functional relevance, 
we examined the ability of NTPase in inhibiting IFN-β promoter 
activation induced by RIG-I-IN in TRIM6 knockdown cells. 
TRIM6-specific siRNA or control siRNA was transfected into 
HEK 293T cells. At 24 h posttransfection, cells were cotransfected 
with NTPase expression plasmid or empty vector, reporter plasmid 
p125-Luc and phRL-TK, together with plasmid encoding IFN-β 
inducer RIG-I-IN for another 24  h. The enzymatic activities of 
firefly and renilla luciferase were measured. As shown in Figure 8E, 
the activation of IFN-β promoter induced by RIG-I-IN was 
markedly inhibited in TRIM6 siRNA-transfected cells, although 
the activation was still detectable, in agreement with a previous 
report (Rajsbaum et al., 2014b). As expected, this residual IFN-β 
induction was not significantly affected by exogenous NTPase 
expression with TRIM6 knockdown. The expression of TRIM6, 
NTPase, and RIG-I-IN was confirmed by WB. These results 
together indicate that HuNoV NTPase likely interferes with the 
interaction between IKKε and K48-linked polyubiquitin chains 
synthesized by the TRIM6, which results in the inhibition of 
IKKε, leading to the suppression of IFN-β production.
Zheng et al. HuNoV NTPase Inhibits IFN-β Production
Frontiers in Microbiology | www.frontiersin.org 13 July 2021 | Volume 12 | Article 687933
A B
C D
FIGURE 7 | The 1-179 aa domain of NTPase inhibits IFN-β production in the same manner as full-length NTPase. (A) The 1-179 aa domain of NTPase inhibits the 
phosphorylation of IKKε and IRF-3 as does full-length NTPases. 3 μg plasmid expressing HA-tagged NTPase, truncated NTPase, or empty vector was transfected 
into HEK 293T cells preseeded in 6-well plates. At 24 h posttransfection, cells were stimulated with or without SeV for 16 h. Total protein was isolated. WB was 
performed to examine IKKε, p-IKKε, IRF-3, and p-IRF-3 using corresponding Abs. The expression of NTPase and the truncated NTPase was monitored using anti-
HA Ab. (B,C) The 1-179 aa domain of NTPase inhibits IRF-3 nuclear translocation. (B) 3 μg NTPase, truncated NTPase expression plasmid, or empty vector was 
transfected into HEK 293T cells preseeded in 6-well plates for 24 h followed by stimulation with or without SeV for 16 h. Cytoplasmic and nuclear proteins were 
isolated. IRF-3 levels were measured with anti-IRF-3 Ab. β-actin and proliferating cell nuclear antigen were used as loading controls for cytoplasmic and nuclear 
proteins, respectively. (C) 3 μg HA-tagged NTPase, truncation expression plasmid, or empty vector was transfected into HeLa cells preseeded in 35-mm dishes. At 
24 h posttransfection, cells were stimulated with or without SeV for 16 h. Cells were incubated with mouse anti-HA Ab and rabbit anti-IRF-3 pAb, followed by Alexa 
Fluor 488-labeled Goat Anti-Mouse IgG (H + L) (green) and Alexa Fluor 647-labeled Goat Anti-Rabbit IgG (H + L) (red) as the secondary Abs. Cell nuclei (blue) were 
stained with DAPI. The images were acquired by fluorescence microscopy using a 60 × objective. One representative experiment out of three is shown. (D) The 
1-179 aa domain of NTPase interacts with IKKε as does full-length NTPases. HEK 293T cells in 6-well plates were cotransfected with 1.5 μg HA-tagged NTPase or 
truncated NTPase expression plasmid together with 1.5 μg plasmid expressing Flag-tagged IKKε or empty vector for 40 h. A mouse anti-Flag Ab was used for Co-
IP of cell lysates with normal IgG being used as a negative control. Co-IP products and 5% input samples were examined using rabbit anti-HA and mouse anti-Flag 
Abs with WB. One representative experiment out of three is shown for WB. CE, cytoplasmic protein extract; NE, nuclear protein extract.
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FIGURE 8 | HuNoV NTPase reduces the association of IKKε with unanchored K48-linked polyubiquitin chains and tripartite motif-containing 6 (TRIM6). (A) HuNoV 
NTPase suppresses the interaction of IKKε with K48-linked polyubiquitin chains. HEK 293T cells in 6-well plates were cotransfected with 1.5 μg plasmid expressing 
HA-tagged NTPase or truncated NTPase together with 1.5 μg Flag-tagged IKKε expression plasmid or empty vector for 40 h. A mouse anti-Flag Ab was used for 
(Continued)
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DISCUSSION
Although HuNoV infection in the gnotobiotic pig model and 
HIEs was shown to be  controlled in the presence of IFN-β, 
HuNoV itself did not induce IFN-β expression (Souza et  al., 
2007; Jung et  al., 2012; Lin et  al., 2019, 2020; Hosmillo et  al., 
2020), implying that HuNoV may inhibit the production of IFN-β 
to evade the host immunity. Due to the lack of an efficient in 
vitro culture system to perform experiments in the context of 
viral infection, HuNoV cDNA clone was analyzed as an alternative. 
It was reported that GII.3 HuNoV cDNA clone, which efficiently 
generates double-stranded RNAs, did not induce detectable type 
I IFN responses but rather inhibited IFN-β production (Qu et al., 
2016). In this study, we  showed that a cDNA clone of the most 
prevalent HuNoV GII.4 genotype inhibited IFN-β production. 
Furthermore, HuNoV NTPase was shown to inhibit not only 
the promoter activity of IFN-β but also the mRNA and protein 
production of IFN-β. In the condition of NTPase knockdown 
with siRNA, the HuNoV cDNA clone was shown to induce 
IFN-β production (Supplementary Figure S2), indicating that 
NTPase may be  a key viral component of HuNoV responsible 
for inhibiting IFN-β production.
IRF-3 signal pathway is known to play a critical role in 
viral and bacterial innate immune responses by regulating 
IFN-β production (Sato et al., 1998; Barnes et al., 2002). Several 
viral components from different viruses have been shown to 
inhibit IFN-β production via interfering with IRF-3 signal 
pathway (Fensterl et  al., 2005; Daffis et  al., 2007; Paulmann 
et  al., 2008). In this study, we  found that NTPase inhibited 
the activity of IRF-3-responsive promoter. Upon activation, 
IRF-3 phosphorylates and translocates from the cytoplasm to 
the nucleus, resulting in transcription induction of the gene 
encoding IFN-β (Sharma et  al., 2003). HuNoV NTPase in this 
study was demonstrated to reduce the phosphorylation of IRF-3 
and thereby inhibit IRF-3 localization to the nucleus.
For RNA viruses, the major sensors RIG-I and MDA5 bind 
the adaptor molecule IPS1 upon virus infection, which activates 
TBK1 and IKKε, resulting in IRF-3 phosphorylation (Chiang 
et  al., 2014; Kell and Gale, 2015). By assessing these IFN-β 
inducers in the IRF-3 signal pathway, we  found that NTPase 
suppressed RIG-I-IN-, IPS1-, TBK1-, or IKKε but not IRF-3-
induced activation of IFN-β promoter in a dose-dependent 
manner, suggesting that NTPase inhibits IFN-β production 
probably at the stage of TBK1/IKKε kinases in IRF-3 signal pathway. 
It is known that IKKε is important for IRF-3 phosphorylation 
(Fitzgerald et  al., 2003; Fang et  al., 2017). Several viruses have 
been shown to inhibit IRF-3 activation by targeting IKKε (Pythoud 
et  al., 2012; Bharaj et  al., 2016; Lundberg et  al., 2019; Fang 
et  al., 2020; Wong et  al., 2020). Indeed, HuNoV NTPase was 
demonstrated to interact with IKKε and reduce its phosphorylation. 
We revealed that HuNoV NTPase inhibits the activation of IRF-3 
by targeting IKKε.
Ubiquitination of IKKε is required to induce IRF-3 
phosphorylation and nuclear localization, resulting in the 
activation of IFN-β promoter (Ikeda et  al., 2007). Unanchored 
K48-linked polyubiquitin chains which are synthetized by the 
E3-ubiquitin ligase TRIM6, interact with IKKε, and promote 
IKKε activation (Versteeg et al., 2013; Rajsbaum et al., 2014a,b). 
It is known that Nipah Virus M targets TRIM6 to inhibit 
K48-linked polyubiquitin chains, leading to the inhibition of 
IKKε activation (Bharaj et  al., 2016). In our study, we  found 
that HuNoV NTPase suppressed the interaction of IKKε with 
unanchored K48-linked polyubiquitin and TRIM6. However, 
IFN-β induction was not significantly affected by exogenous 
NTPase expression with TRIM6 knockdown. These findings 
together indicate that the interaction of NTPase with IKKε 
likely blocks the interaction of IKKε with K48-linked 
polyubiquitin chains synthetized by TRIM6, leading to the 
inhibition of IKKε activation.
In the case of IFN-I signaling, both STAT1 and STAT2 are 
activated, leading to the formation of heterodimers that associate 
with the IRF-9 to form a transcription factor complex, termed 
IFN-stimulated gene factor 3 (Levy et  al., 1989; Fu et  al., 
1990). In contrast, IFN-II (IFN-γ) signaling results in the 
recruitment and tyrosine phosphorylation of two STAT1 proteins, 
leading to the formation of STAT1:STAT1 homodimers, a 
complex referred to as the gamma-activated factor (Shuai et al., 
1992). The activated IKKε phosphorylates STAT1 and inhibits 
its homodimerization, thereby regulating the balance between 
type I  and type II IFN responses (Ng et  al., 2011). As NTPase 
was determined to inhibit IKKε activation, we  speculated that 
NTPase may regulate type I  and type II IFN signal pathway. 
Indeed, we  found that NTPase inhibited the expression of 
MDA5 and STAT1 induced by IFN-β but promoted the 
expression of IRF-1 and STAT1 induced by IFN-γ 
(Supplementary Figure S3). These may explain why GII.4 
HuNoV induces ISGs through type II IFN pathways depending 
on STAT1 (Lin et  al., 2020).
FIGURE 8 | Co-IP of cell lysates with normal IgG being used as a negative control. 5% input samples were examined by WB using anti-HA Ab, anti-Flag Ab, and 
anti-K48-linked polyubiquitin Ab. IP products were examined by WB using anti-Flag Ab and anti-K48-linked polyubiquitin Ab. (B) Blot intensity for K48-linked 
polyubiquitin which interacted with IKKε was quantified using Image Lab with statistical significance being analyzed from three independent experiments. (C) HuNoV 
NTPase reduces the interaction of IKKε with TRIM6. HEK 293T cells in 6-well plates were cotransfected with 1.5 μg plasmid expressing HA-tagged NTPase or 
truncated NTPase together with 1.5 μg Flag-tagged IKKε expression plasmid or empty vector for 40 h. A mouse anti-Flag Ab was used for Co-IP of cell lysates with 
normal IgG being used as a negative control. 5% input samples were examined by WB using anti-HA Ab, anti-Flag Ab, and anti-TRIM6 Ab. IP products were 
examined by WB using anti-Flag Ab and anti-TRIM6 Ab. (D) Blot intensity for TRIM6 which interacted with IKKε was quantified using Image Lab with statistical 
significance being analyzed from three independent experiments. (E) The IFN-β induction was not affected by NTPase with TRIM6 knockdown. HEK 293T cells in 
48-well plates were transfected with 5 nm siRNA against TRIM6 or control siRNA. 24 h later, cells were cotransfected with 200 ng of HA-tagged NTPase expression 
plasmid or empty vector together with 100 ng p125-Luc and 20 ng phRL-TK, together with 20 ng RIG-I-IN expression plasmid for another 24 h. Reporter activities 
were determined with DLR assay. The expression of TRIM6, NTPase, and RIG-I-IN was determined with anti-TRIM6 Ab, anti-HA Ab, and anti-Flag Ab, respectively. 
One representative experiment out of three is shown for WB. For graphs, data shown are mean ± SD of three independent experiments, with each condition 
performed in triplicate. ***p < 0.001; **p < 0.01; and ns, not significant.
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Mitochondrion functions as a signaling platform for RLRs 
(Cloonan and Choi, 2013; Banoth and Cassel, 2018). Two 
mitochondrion targeting domains were identified in the 
C-terminal region (96-366 aa) of GII.4-NTPase (Yen et  al., 
2018). It is tempting to know whether NTPase-mediated 
inhibition of IFN-β production is related to its mitochondrial 
location. We  showed that NTPase 96-366 aa region had no 
impact on the production of IFN-β, implying that NTPase 
inhibits IFN-β production regardless of its mitochondria location. 
The N-terminal 1-179 aa region of GII.4 HuNoV NTPase was 
revealed to be  sufficient in mediating the formation of 
homodimers or homo-oligomers and the interaction of NTPase 
with two other nonstructural proteins p48 and p22 (Yen et  al., 
2018). In our study, NTPase was shown to inhibit IFN-β 
production by interacting with IKKε. It is likely the 1-179 aa 
region of NTPase is responsible for inhibiting IFN-β production. 
In agreement, we  reveled that NTPase 1-179 aa and 1-271 aa 
region but not 1-95 aa or 180-366 aa region inhibited IFN-β 
production. The 1-179 aa domain of NTPase inhibited IFN-β 
production in the same manner as its full-length via interacting 
with IKKε. These findings strongly suggest that the function 
domain (1-179 aa) is important for NTPase-mediated inhibition 
of IFN-β production. HuNoV NTPase plays an important role 
in RNA synthesis in vitro (Pfister and Wimmer, 2001; Han 
et  al., 2018; Li et  al., 2018) and contains motifs A (GI HuNoV 
NTPase 162-169 aa), B (GI HuNoV NTPase 212 and 213 aa), 
and C (257-260 aa) relating to NTPase activity (Liu et  al., 
1996; Li et  al., 2018). Mutations in motif A, B, or C abolished 
NTPase activity (Pfister and Wimmer, 1999). We  found that 
the 1-179 aa domain of NTPase containing motif A but not 
motif B or C is crucial for inhibiting IFN-β production. All 
these together suggest that HuNoV NTPase inhibits IFN-β 
production independent of its NTPase activity.
In summary, we  report here that the cDNA clone of GII.4 
HuNoV inhibits IFN-β production and its NTPase plays a 
critical role in the process. We  reveal that HuNoV NTPase 
inhibits IFN-β production by inhibiting the phosphorylation 
and nuclear translocation of IRF-3. We  further demonstrate 
that HuNoV NTPase interacts with IKKε and such interaction 
likely blocks the interaction of IKKε with the unanchored 
K48-linked polyubiquitin chains synthesized by TRIM6, resulting 
in inhibition of IKKε activation. We  provide evidence that 
the 1-179 aa domain of NTPase is the functional region to 
interrupt IFN-β production. Our findings highlight the 
significance of GII.4 HuNoV NTPase in suppressing IFN-β 
production, providing a novel mechanism underlying how 
HuNoV evades the host innate immunity.
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